Seattle breakthrough offers Spokane boy relief from rare hunger condition
A new FDA-approved therapy, setmelanotide, is providing relief for patients with hypothalamic obesity caused by brain injury and tumors.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
A boy from Spokane has found treatment for constant hunger resulting from brain damage, following a breakthrough in Seattle. The FDA has approved a new therapy for obesity caused by brain injury.
Coverage from The ASCO Post and the limbic emphasizes the use of setmelanotide, noting that the drug cuts BMI in hypothalamic obesity trials involving patients with brain tumors. Local reporting from KREM and The Spokesman-Review focuses on the individual impact on the Spokane patient.
Future focus remains on the application of setmelanotide for patients with acquired hypothalamic obesity and the broader rollout of the FDA-approved therapy.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 6h ago.
Quick answers
What is the name of the therapy being used?
The therapy is called setmelanotide.
What specific condition does this treatment address?
It treats hypothalamic obesity caused by brain injury and brain tumors.
Who is the FDA-approved therapy helping in local reports?
A boy from Spokane suffering from a rare hunger condition caused by brain damage.
Coverage (5)
- Setmelanotide in Patients With Acquired Hypothalamic Obesity From Brain Tumors The ASCO Post · 1d ago
- ‘Back to living life’: Spokane boy finds treatment to constant hunger caused by brain damage The Spokesman-Review · 1d ago
- Setmelanotide cuts BMI in hypothalamic obesity trial the limbic · 1d ago
- FDA approves new therapy for obesity caused by brain injury NR Times · 1d ago
- Seattle breakthrough offers Spokane boy relief from rare hunger condition KREM · 1d ago
Topics
Related trends
FDA still focused on Taylor Farms lettuce as Cyclospora source despite retracted test
The FDA continues to target Taylor Farms as the source of a cyclosporiasis outbreak despite a retracted test result.
Alzheimer's: Real-world study confirms Leqembi therapy benefits
The FDA has approved a subcutaneous, at-home initiation dose of Leqembi for patients with early Alzheimer's disease.
Explosive diarrhea outbreak: Lettuce tests positive for cyclospora, FDA says
A widespread Cyclospora parasite outbreak has triggered an iceberg lettuce recall across 27 US states, impacting major retailers and fast-food chains.
Taylor Farms lettuce sample tests positive for Cyclospora as recall expands
Taylor Farms has initiated a wide-reaching lettuce recall following a positive test for the parasite Cyclospora.
Cyclospora: iceberg lettuce recalled in 27 states and more products may follow
A massive recall of iceberg lettuce across 27 states is underway following a cyclosporiasis outbreak linked to Taylor Farms.
Pillsbury recalls 2 bread products over potential glass contamination
General Mills has issued a recall for Pillsbury bread rolls due to potential glass contamination across multiple U.S. states.